TrialPloS one2018

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.

Alfred B Tiono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.